The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis

Dig Liver Dis. 2015 May;47(5):432-5. doi: 10.1016/j.dld.2015.02.002. Epub 2015 Feb 11.

Abstract

Background: The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only six published cases so far.

Methods: Here we report two cases showing the clinical manifestations of both primary biliary cirrhosis and primary sclerosing cholangitis.

Results: In one case the overlap condition was associated with psoriatric arthritis, and the patient successfully underwent dual treatment with ursodeoxycholic acid and the anti-tumour necrosis factor-alpha agent adalimumab. In the second case, the predominant condition was, initially, an antimitochondrial antibody-negative primary biliary cirrhosis with progressive course towards end-stage liver disease; the patient then developed either antimitochondrial antibody positivity or changes in the biliary tree compatible with primary sclerosing cholangitis.

Conclusions: These two cases add information on a controversial issue in the literature, and indicate the importance of recognizing a possible overlap syndrome to optimize treatment.

Keywords: Overlap syndrome; Primary biliary cirrhosis; Primary sclerosing cholangitis.

Publication types

  • Case Reports

MeSH terms

  • Arthritis, Psoriatic / blood
  • Arthritis, Psoriatic / diagnosis
  • Arthritis, Psoriatic / pathology
  • Autoantibodies / blood
  • Cholangitis, Sclerosing / blood
  • Cholangitis, Sclerosing / diagnosis*
  • Cholangitis, Sclerosing / drug therapy*
  • Cholangitis, Sclerosing / pathology
  • Comorbidity
  • Female
  • Humans
  • Liver / pathology*
  • Liver Cirrhosis, Biliary / blood
  • Liver Cirrhosis, Biliary / diagnosis*
  • Liver Cirrhosis, Biliary / drug therapy*
  • Liver Cirrhosis, Biliary / pathology
  • Middle Aged
  • Mitochondria / immunology
  • Syndrome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Autoantibodies
  • Tumor Necrosis Factor-alpha
  • Ursodeoxycholic Acid